FDC Ltd (FDC) — concall transcript | 30 September 2023

· BSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
FDC reported H1 revenue growth of 9% to INR1,023 crores and PAT growth of 47% to INR180 crores, announced a share buyback of 31 lakh shares at INR500 each.
🔄 What Changed
33% export revenue growth and 47% PAT growth represent material improvements; share buyback announced; domestic volume stagnation and one-time expenses noted as challenges.
🔮 What's Next
Capex of INR170 crores planned for new corporate office and R&D center over 12-15 months; focus on geographic expansion into East India and new therapeutic areas; price growth expected to continue amid regulatory constraints.
💡 Investor Takeaway
Share buyback signals confidence in valuation, but domestic volume stagnation and regulatory pressures on pricing pose near-term headwinds for growth.

FDC Ltd reported 9% H1 revenue growth to INR1,023 crores and 47% PAT growth to INR180 crores, driven by 33% export growth and 2% API growth, while announcing a buyback of 31 lakh shares at INR500 each; management highlighted domestic volume stagnation, 4.9% price growth, expansion into East India, and new therapeutic areas like Derma and Nutraceuticals, with Capex plans of INR170 crores for new facilities and R&D, and no demerger plans.

📄 View Original Announcement (PDF)

About FDC Ltd (FDC)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹5,534.73 Cr P/E: 18.9 ROE: 12.8% ROCE: 17.3% Div Yield: 1.47%

View full FDC stock details →

📡 Get AI alerts when FDC files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track FDC — Free

📊 More FDC filings

See all FDC filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when FDC files new disclosures

Track FDC filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track FDC — Free

Free account · 2 AI queries/day